Two phase I studies in healthy Chinese ( NCT01458743 ) and Western ( NCT01612507 ) subjects evaluated the pharmacokinetics ( PK ) and safety of single and multiple ceftaroline fosamil 600 mg infusions administered every 8 or 12 hours ( q8h or q12h ) .